|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ren SC, Chen R and Sun YH: Prostate cancer
research in China. Asian J Androl. 15:350–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye D and Zhu Y: Epidemiology of prostate
cancer in China: An overview and clinical implication. Zhonghua Wai
Ke Za Zhi. 53:249–252. 2015.(In Chinese). PubMed/NCBI
|
|
4
|
Ibrahim SA, Hassan H and Götte M: MicroRNA
regulation of proteoglycan function in cancer. FEBS J.
281:5009–5022. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Janga SC and Vallabhaneni S: MicroRNAs as
post-transcriptional machines and their interplay with cellular
networks. Adv Exp Med Biol. 722:59–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guedes J, Cardoso AL and de Lima Pedroso
MC: Involvement of microRNA in microglia-mediated immune response.
Clin Dev Immunol. 2013:1868722013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
8
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McGuire A, Brown JA and Kerin MJ:
Metastatic breast cancer: The potential of miRNA for diagnosis and
treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang
Y, Li J, Bian Z, Liang X, Cai X, et al: Exogenous plant MIR168a
specifically targets mammalian LDLRAP1: Evidence of cross-kingdom
regulation by microRNA. Cell Res. 22:107–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gismondi A, Di Marco G and Canini A:
Detection of plant microRNAs in honey. PLoS One. 12:e01729812017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gandellini P, Folini M and Zaffaroni N:
Emerging role of microRNAs in prostate cancer: Implications for
personalized medicine. Discov Med. 9:212–218. 2010.PubMed/NCBI
|
|
14
|
Leite KR, Morais DR, Florez MG, Reis ST,
Iscaife A, Viana N, Moura CM, Silva IA, Katz BS, Pontes J Jr, et
al: The role of microRNAs 371 and 34a in androgen receptor control
influencing prostate cancer behavior. Urol Oncol. 33(267): e15–22.
2015.
|
|
15
|
Sun X, Liu Z, Yang Z, Xiao L, Wang F, He
Y, Su P, Wang J and Jing B: Association of microRNA-126 expression
with clinicopathological features and the risk of biochemical
recurrence in prostate cancer patients undergoing radical
prostatectomy. Diagn Pathol. 8:2082013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tinkov S, Bekeredjian R, Winter G and
Coester C: Microbubbles as ultrasound triggered drug carriers. J
Pharm Sci. 98:1935–1961. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanguino A, Lopez-Berestein G and Sood AK:
Strategies for in vivo siRNA delivery in cancer. Mini Rev Med Chem.
8:248–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ibsen S, Schutt CE and Esener S:
Microbubble-mediated ultrasound therapy: A review of its potential
in cancer treatment. Drug Des Devel Ther. 7:375–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mayer CR, Geis NA, Katus HA and
Bekeredjian R: Ultrasound targeted microbubble destruction for drug
and gene delivery. Expert Opin Drug Deliv. 5:1121–1138. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kiessling F, Fokong S, Koczera P, Lederle
W and Lammers T: Ultrasound microbubbles for molecular diagnosis,
therapy, and theranostics. J Nucl Med. 53:345–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Miyoshi H and Nakamura M:
Encapsulated ultrasound microbubbles: Therapeutic application in
drug/gene delivery. J Control Release. 114:89–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Srivastava A, Goldberger H, Dimtchev A,
Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen
LN, et al: MicroRNA profiling in prostate cancer-the diagnostic
potential of urinary miR-205 and miR-214. PLoS One. 8:e769942013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leong-Poi H, Kuliszewski MA, Lekas M,
Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ and
Lindner JR: Therapeutic arteriogenesis by ultrasound-mediated
VEGF165 plasmid gene delivery to chronically ischemic skeletal
muscle. Circ Res. 101:295–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang D, Gao YH, Tan KB, Zuo ZX, Yang WX,
Hua X, Li PJ, Zhang Y and Wang G: Inhibition of hepatic fibrosis
with artificial microRNA using ultrasound and cationic
liposome-bearing microbubbles. Gene Ther. 20:1140–1148. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kubota H, Fukuta K, Yamada K, Hirose M,
Naruyama H, Yanai Y, Yamada Y, Watase H, Kawai N, Tozawa K and
Yasui T: Feasibility of metronomic chemotherapy with
tegafur-uracil, cisplatin, and dexamethasone for
docetaxel-refractory prostate cancer. J Rural Med. 12:112–119.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tricoli JV and Jacobson JW: MicroRNA:
Potential for cancer detection, diagnosis, and prognosis. Cancer
Res. 67:4553–4555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lim LP, Glasner ME, Yekta S, Burge CB and
Bartel DP: Vertebrate microRNA genes. Science. 299:15402003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wienholds E, Kloosterman WP, Miska E,
Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen
S and Plasterk RH: MicroRNA expression in zebrafish embryonic
development. Science. 309:310–311. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mao Y, Wu S, Zhao R and Deng Q: MiR-205
promotes proliferation, migration and invasion of nasopharyngeal
carcinoma cells by activation of AKT signalling. J Int Med Res.
44:231–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Sun Z, Ren P, Lee RJ, Xiang G, Lv
Q, Han W, Wang J, Ge S and Xie M: Ultrasound-targeted microbubble
destruction (UTMD) assisted delivery of shRNA against PHD2 into
H9C2 cells. PLoS One. 10:e01346292015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen H and Hwang JH: Ultrasound-targeted
microbubble destruction for chemotherapeutic drug delivery to solid
tumors. J Ther Ultrasound. 1:102013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen ZY, Lin Y, Yang F, Jiang L and Ge Sp:
Gene therapy for cardiovascular disease mediated by ultrasound and
microbubbles. Cardiovasc Ultrasound. 11:112013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wan C, Li F and Li H: Gene therapy for
ocular diseases meditated by ultrasound and microbubbles (Review).
Mol Med Rep. 12:4803–4814. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma J, Du LF, Chen M, Wang HH, Xing LX,
Jing LF and Li YH: Drug-loaded nano-microcapsules delivery system
mediated by ultrasound-targeted microbubble destruction: A
promising therapy method. Biomed Rep. 1:506–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nande R, Howard CM and Claudio PP:
Ultrasound-mediated oncolytic virus delivery and uptake for
increased therapeutic efficacy: State of art. Oncolytic Virother.
4:193–205. 2015.PubMed/NCBI
|
|
41
|
Liu F, Wang J, Fu Q, Zhang X, Wang Y, Liu
J, Huang J and Lv X: VEGF-activated miR-144 regulates autophagic
survival of prostate cancer cells against Cisplatin. Tumour Biol.
Nov 13–2015.(Epub ahead of print).
|
|
42
|
Pennati M, Lopergolo A, Profumo V, De
Cesare M, Sbarra S, Valdagni R, Zaffaroni N, Gandellini P and
Folini M: miR-205 impairs the autophagic flux and enhances
cisplatin cytotoxicity in castration-resistant prostate cancer
cells. Biochem Pharmacol. 87:579–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou P, Ma L, Zhou J, Jiang M, Rao E, Zhao
Y and Guo F: miR-17-92 plays an oncogenic role and conveys
chemo-resistance to cisplatin in human prostate cancer cells. Int J
Oncol. 48:1737–1748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng X, Ji P and Hu J: Sonoporation using
microbubbles promotes lipofectamine-mediated siRNA transduction to
rat retina. Bosn J Basic Med Sci. 11:147–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Seger R and Krebs EG: The MAPK signaling
cascade. FASEB J. 9:726–735. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hasegawa T, Adachi R, Iwakata H, Takeno T,
Sato K and Sakamaki T: ErbB2 signaling epigenetically suppresses
microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast
cancer. FEBS Open Bio. 7:1154–1165. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hu N, Feng C, Jiang Y, Miao Q and Liu H:
Regulative effect of Mir-205 on osteogenic differentiation of bone
mesenchymal stem cells (BMSCs): Possible Role of SATB2/Runx2 and
ERK/MAPK Pathway. Int J Mol Sci. 16:10491–10506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Iorio MV, Casalini P, Piovan C, Di Leva G,
Merlo A, Triulzi T, Menard S, Croce CM and Tagliabue E:
microRNA-205 regulates HER3 in human breast cancer. Cancer Res.
69:2195–2200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schwarzenbach H: The clinical relevance of
circulating, exosomal miRNAs as biomarkers for cancer. Expert Rev
Mol Diagn. 15:1159–1169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lin CW, Kao SH and Yang PC: The miRNAs and
epithelial-mesenchymal transition in cancers. Curr Pharm Des.
20:5309–5318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pieters T and van Roy F: Role of cell-cell
adhesion complexes in embryonic stem cell biology. J Cell Sci.
127:2603–2613. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li L, Wang S, Yang X, Long S, Xiao S, Wu W
and Hann SS: Traditional Chinese medicine, Fuzheng KangAi
decoction, inhibits metastasis of lung cancer cells through the
STAT3/MMP9 pathway. Mol Med Rep. 16:2461–2468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ha GH, Park JS and Breuer EK: TACC3
promotes epithelial-mesenchymal transition (EMT) through the
activation of PI3K/Akt and ERK signaling pathways. Cancer Lett.
332:63–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pan H, Jiang T, Cheng N, Wang Q, Ren S, Li
X, Zhao C, Zhang L, Cai W and Zhou C: Long non-coding RNA BC087858
induces non-T790M mutation acquired resistance to EGFR-TKIs by
activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell
lung cancer. Oncotarget. 7:49948–49960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang H, Sun JD, Yan LJ and Zhao XP:
PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC)
progression via activating p38/AKT/ERK/EMT signal pathway. Biochem
Biophys Res Commun. 478:845–851. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang B, Lv K, Chen W, Zhao J, Luo J, Wu J,
Li Z, Qin H, Wong TS, Yang W, et al: miR-375 and miR-205 regulate
the invasion and migration of laryngeal squamous cell carcinoma
synergistically via AKT-Mediated EMT. Biomed Res Int.
2016:96527892016. View Article : Google Scholar : PubMed/NCBI
|
